Impact of implementing a stroke code on the door to needle time during Hajj at a tertiary center in Makkah, Saudi Arabia

References

1. 1.↵
   1. Paramasivam S.

   Current trends in the management of acute ischemic stroke. Neurol India 2015; 63: 665–672.

   OpenUrl
2. 2.↵
   1. Benjamin EJ,
   2. Blaha MJ,
   3. Chiuve SE,
   4. Cushman M,
   5. Das SR,
   6. Deo R, et al

   ; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update: A report from the American heart association. Circulation 2017; 135: e146 603.

   OpenUrl
3. 3.↵
   1. Béjot Y,
   2. Delpont B,
   3. Giroud M.

   Rising stroke incidence in young adults: more epidemiological evidence, more questions to be answered. J Am Heart Assoc 2016; 5: e003661.

   OpenUrlFREE Full Text
4. 4.↵
   The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768–774.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Emberson J,
   2. Lees KR,
   3. Lyden P,
   4. Blackwell L,
   5. Albers G,
   6. Bluhmki E, et al

   ; Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929–1935.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Kamal N,
   2. Smith EE,
   3. Jeerakathil T,
   4. Hill MD.

   Thrombolysis: improving door-to-needle times for ischemic stroke treatment - A narrative review. Int J Stroke 2018; 13: 268–276.

   OpenUrlPubMed
8. 8.↵
   1. Almekhlafi MA,
   2. Alhazmi MA,
   3. Alsulami SS,
   4. Almorsy SA.

   Incidence and impact of stroke during Hajj. Results of 2015 Hajj stroke registry. Neurosciences (Riyadh) 2017; 22(3): 181–185.

   OpenUrl
9. 9.↵
   1. Chen BY,
   2. Moussaddy A,
   3. Keezer MR,
   4. Deschaintre Y,
   5. Poppe AY.

   Short-and long-term reduction of door-to-needle time in thrombolysis for acute stroke. Can J Neurol Sci 2017; 44: 255–260.

   OpenUrl
10. 10.↵
    1. Gurav SK,
    2. Zirpe KG,
    3. Wadia RS,
    4. Naniwadekar A,
    5. Pote PU,
    6. Tungenwar A, et al.

    Impact of “stroke code”-rapid response Team: an attempt to improve intravenous thrombolysis rate and to shorten door-to-needle time in acute ischemic stroke. Indian J Crit Care Med 2018; 22: 243–248.

    OpenUrl
11. 11.↵
    1. Mohedano AI,
    2. Pastor AG,
    3. Otero FD,
    4. Alen PV,
    5. Gómez MM,
    6. Campo PS, et al.

    A new protocol reduces median door-to-needle time to the benchmark of 30 minutes in acute stroke treatment. Neurología (English Edition) 2021; 36: 487–494.

    OpenUrl
12. 12.↵
    1. Dharia R,
    2. Carney M,
    3. O’Connor M,
    4. D’Ambrosio R.

    IHI ID 24 Improving door-to-groin puncture time for acute stroke patients in the ER with large vessel occlusion. BMJ Open Qual 2018; 7: A34–A35.

    OpenUrl